Search research articles
Contact Us
Filters
Showing results (141-150 of 259) with videos related to
Page
of 26
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 6, 2021
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
Claudia Kesch, Leubet Yirga, Katharina Dendl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2011
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium
Neil E Fleshner, Linda Kapusta, Bryan Donnelly, et al.
Urology Practice
|
November 7, 2024
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists
Arnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, et al.
The Journal of Cell Biology
|
March 25, 2015
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1
Syam Prakash Somasekharan, Amal El-Naggar, Gabriel Leprivier, et al.
European Urology
|
February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
Stephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Standard treatments induce antigen-specific immune responses in prostate cancer
Nancy J Nesslinger, Robert A Sahota, Brad Stone, et al.
Translational Oncology
|
February 13, 2013
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
Khalil A Choucair, Karl-Philippe Guérard, Joshua Ejdelman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2013
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
Guillaume Wettstein, Pierre-Simon Bellaye, Martin Kolb, et al.
Cancer Research
|
June 4, 2008
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis
Dong Lin, Akira Watahiki, Jane Bayani, et al.
European Urology
|
May 20, 2014
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies
Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al.
Page
of 26
Search research articles
Search
Showing results (141-150 of 259) with videos related to
Sort By:
Page
of 26
European Journal of Nuclear Medicine and Molecular Imaging
|
July 6, 2021
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
Claudia Kesch, Leubet Yirga, Katharina Dendl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2011
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium
Neil E Fleshner, Linda Kapusta, Bryan Donnelly, et al.
Urology Practice
|
November 7, 2024
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists
Arnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, et al.
The Journal of Cell Biology
|
March 25, 2015
YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1
Syam Prakash Somasekharan, Amal El-Naggar, Gabriel Leprivier, et al.
European Urology
|
February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
Stephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Standard treatments induce antigen-specific immune responses in prostate cancer
Nancy J Nesslinger, Robert A Sahota, Brad Stone, et al.
Translational Oncology
|
February 13, 2013
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
Khalil A Choucair, Karl-Philippe Guérard, Joshua Ejdelman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 5, 2013
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
Guillaume Wettstein, Pierre-Simon Bellaye, Martin Kolb, et al.
Cancer Research
|
June 4, 2008
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis
Dong Lin, Akira Watahiki, Jane Bayani, et al.
European Urology
|
May 20, 2014
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies
Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albigès, et al.
Page
of 26